PMHS
Polomar Health Services, Inc.
Going-concern doubt
— flagged Jun 1, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date of filing. Over the next twelve months, management plans to raise additional capital upon the closing of the Altanine Merger transaction, invest its working capital resources in Polomar’s pharmacy operations and in other potential business opportunities. However, there is no guarantee the Company will raise sufficient capital to continue operations.”View the 10-Q filed Jun 1, 2026
Company with tickers: PMHS
CIK
1265521
CUSIP
898391206
Shares Outstanding
28,053,090
Website
https://www.polomarhs.com
Investor Relations
https://www.polomarhs.com/
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,005,519 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $455,030 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| Gross Profit | $550,489 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| Operating Expenses | $557,391 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| Research & Development | — | ||||
| Operating Income | $-6,902 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| Net Income | $-25,377 | USD | 2026-03-31 | 10-Q | 2026-06-01 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-06-01 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-06-01 |